Inhaled nitric oxide effects on lung structure and function in chronically ventilated preterm lambs.

RATIONALE Inhaled nitric oxide (iNO) can reverse neonatal pulmonary hypertension and bronchoconstriction and reduce proliferation of cultured arterial and airway smooth muscle cells. OBJECTIVES To see if continuous iNO from birth might reduce pulmonary vascular and respiratory tract resistance (PVR, RE) and attenuate growth of arterial and airway smooth muscle in preterm lambs with chronic lung disease. METHODS Eight premature lambs received mechanical ventilation for 3 weeks, four with and four without iNO (5-15 ppm). Four term lambs, mechanically ventilated without iNO for 3 weeks, served as additional control animals. MEASUREMENTS PVR and RE were measured weekly. After 3 weeks, lung tissue was processed for quantitative image analysis of smooth muscle abundance around small arteries (SMart) and terminal bronchioles (SMtb). Radial alveolar counts were done to assess alveolar number. Endothelial NO synthase (eNOS) protein in arteries and airways was measured by immunoblot analysis. MAIN RESULTS At study's end, PVR was similar in iNO-treated and untreated preterm lambs; PVR was less in iNO-treated preterm lambs compared with term control animals. RE in iNO-treated lambs was less than 40% of RE measured in preterm control animals. SMart was similar in iNO-treated and both groups of control lambs; SMtb in lambs given iNO was significantly less (approximately 50%) than in preterm control animals. Radial alveolar counts of iNO-treated lambs were more than twice that of preterm control animals. eNOS was similar in arteries and airways of iNO-treated preterm lambs compared with control term lambs. CONCLUSIONS iNO preserves structure and function of airway smooth muscle and enhances alveolar development in preterm lambs with chronic lung disease.

[1]  J. Crapo,et al.  Inhaled NO improves early pulmonary function and modifies lung growth and elastin deposition in a baboon model of neonatal chronic lung disease. , 2005, American journal of physiology. Lung cellular and molecular physiology.

[2]  P. Mourani,et al.  Pulmonary vascular effects of inhaled nitric oxide and oxygen tension in bronchopulmonary dysplasia. , 2004, American journal of respiratory and critical care medicine.

[3]  S. Abman,et al.  Inhaled nitric oxide attenuates pulmonary hypertension and improves lung growth in infant rats after neonatal treatment with a VEGF receptor inhibitor. , 2004, American journal of physiology. Lung cellular and molecular physiology.

[4]  T. Nagayasu,et al.  Inhaled nitric oxide attenuates apoptosis in ischemia-reperfusion injury of the rabbit lung. , 2004, The Annals of thoracic surgery.

[5]  B. Yoder,et al.  Treatment of immature baboons for 28 days with early nasal continuous positive airway pressure. , 2004, American journal of respiratory and critical care medicine.

[6]  C. Ackerley,et al.  Defective Lung Vascular Development and Fatal Respiratory Distress in Endothelial NO Synthase–Deficient Mice: A Model of Alveolar Capillary Dysplasia? , 2004, Circulation research.

[7]  D. Carlton,et al.  Pulmonary vascular dysfunction in preterm lambs with chronic lung disease. , 2003, American journal of physiology. Lung cellular and molecular physiology.

[8]  A. Dykes,et al.  Microtubule-dependent PKC-α localization in A7r5 smooth muscle cells , 2003 .

[9]  C. Plopper,et al.  Mild hypoxia impairs alveolarization in the endothelial nitric oxide synthase-deficient mouse. , 2003, American journal of physiology. Lung cellular and molecular physiology.

[10]  B. Yoder,et al.  Pulmonary NO synthase expression is attenuated in a fetal baboon model of chronic lung disease. , 2003, American journal of physiology. Lung cellular and molecular physiology.

[11]  G. Schmalzing,et al.  Glu496Ala polymorphism of human P2X7 receptor does not affect its electrophysiological phenotype. , 2003, American journal of physiology. Cell physiology.

[12]  Richard J Martin,et al.  The role of endogenous and exogenous nitric oxide on airway function. , 2002, Seminars in perinatology.

[13]  B. Yoder,et al.  Developmental changes in nitric oxide synthase isoform expression and nitric oxide production in fetal baboon lung. , 2002, American journal of physiology. Lung cellular and molecular physiology.

[14]  N. Voelkel,et al.  Treatment of newborn rats with a VEGF receptor inhibitor causes pulmonary hypertension and abnormal lung structure. , 2002, American journal of physiology. Lung cellular and molecular physiology.

[15]  C. Tribble,et al.  Inhibition of compensatory lung growth in endothelial nitric oxide synthase-deficient mice. , 2002, American journal of physiology. Lung cellular and molecular physiology.

[16]  R. Watkins,et al.  Angiogenic factors and alveolar vasculature: development and alterations by injury in very premature baboons. , 2002, American journal of physiology. Lung cellular and molecular physiology.

[17]  S. Young,et al.  Nitric oxide modulates branching morphogenesis in fetal rat lung explants. , 2002, American journal of physiology. Lung cellular and molecular physiology.

[18]  R. Watkins,et al.  Disrupted pulmonary vasculature and decreased vascular endothelial growth factor, Flt-1, and TIE-2 in human infants dying with bronchopulmonary dysplasia. , 2001, American journal of respiratory and critical care medicine.

[19]  D. Carlton,et al.  Reduced Endothelial Nitric Oxide Synthase in Lungs of Chronically Ventilated Preterm Lambs , 2000 .

[20]  A. W. Murray,et al.  NO protects alveolar type II cells from stretch-induced apoptosis. A novel role for macrophages in the lung. , 2000, American journal of physiology. Lung cellular and molecular physiology.

[21]  R. Bland,et al.  Chronic Lung Disease in Early Infancy , 2000 .

[22]  N. Voelkel,et al.  Inhibition of angiogenesis decreases alveolarization in the developing rat lung. , 2000, American journal of physiology. Lung cellular and molecular physiology.

[23]  T. L. Le Cras,et al.  Early abnormalities of pulmonary vascular development in the Fawn-Hooded rat raised at Denver's altitude. , 2000, American journal of physiology. Lung cellular and molecular physiology.

[24]  D. Carlton,et al.  Chronic Lung Injury in Preterm Lambs: Abnormalities of the Pulmonary Circulation and Lung Fluid Balance , 2000, Pediatric Research.

[25]  J. Cooke,et al.  Nitric oxide induces the synthesis of vascular endothelial growth factor by rat vascular smooth muscle cells. , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[26]  M. Keszler,et al.  Low-dose nitric oxide therapy for persistent pulmonary hypertension of the newborn. Clinical Inhaled Nitric Oxide Research Group. , 2000, The New England journal of medicine.

[27]  R. Lark,et al.  LOW-DOSE NITRIC OXIDE THERAPY FOR PERSISTENT PULMONARY HYPERTENSION OF THE NEWBORN , 2000 .

[28]  J. Coalson 5. PATHOLOGY OF CHRONIC LUNG DISEASE OF EARLY INFANCY , 2000 .

[29]  I. Yuhanna,et al.  Nitric oxide (NO) upregulates NO synthase expression in fetal intrapulmonary artery endothelial cells. , 1999, American journal of respiratory cell and molecular biology.

[30]  A. Knox,et al.  Antiproliferative effects of NO and ANP in cultured human airway smooth muscle. , 1999, American journal of physiology. Lung cellular and molecular physiology.

[31]  R. Tuder,et al.  Abnormal lung growth and the development of pulmonary hypertension in the Fawn-Hooded rat. , 1999, American journal of physiology. Lung cellular and molecular physiology.

[32]  J. Veinot,et al.  Inhaled nitric oxide protects against hyperoxia-induced apoptosis in rat lungs. , 1999, American journal of physiology. Lung cellular and molecular physiology.

[33]  P. O’Farrell,et al.  Nitric Oxide Contributes to Behavioral, Cellular, and Developmental Responses to Low Oxygen in Drosophila , 1999, Cell.

[34]  D. Carlton,et al.  Chronic lung injury in preterm lambs. Disordered respiratory tract development. , 1999, American journal of respiratory and critical care medicine.

[35]  I. Yuhanna,et al.  Nitric oxide synthase isoform expression in the developing lung epithelium. , 1999, The American journal of physiology.

[36]  A. Husain,et al.  Pathology of arrested acinar development in postsurfactant bronchopulmonary dysplasia. , 1998, Human pathology.

[37]  D. Carlton,et al.  Continuous Inhalation of Nitric Oxide From Birth Preserves the Pulmonary Vasoconstrictor Response to Hypoxia in Chronically Ventilated Preterm Lambs• 1614 , 1998, Pediatric Research.

[38]  D. Carlton,et al.  Regulation of Endothelial Nitric Oxide Synthase Expression in Small Pulmonary Arteries and Airways of Chronically Ventilated Preterm Lambs. † 1700 , 1998, Pediatric Research.

[39]  D. Carlton,et al.  Continuous Inhalation of Nitric Oxide From Birth Decreases Airway Resistance and Bronchiolar Smooth Muscle in Chronically Ventilated Preterm Lambs • 1613 , 1998, Pediatric Research.

[40]  R. D. Rudic,et al.  Direct evidence for the importance of endothelium-derived nitric oxide in vascular remodeling. , 1998, The Journal of clinical investigation.

[41]  G. Garcı́a-Cardeña,et al.  Nitric oxide production contributes to the angiogenic properties of vascular endothelial growth factor in human endothelial cells. , 1997, The Journal of clinical investigation.

[42]  D. Carlton,et al.  Role of neutrophils in lung vascular injury and edema after premature birth in lambs. , 1997, Journal of applied physiology.

[43]  Richard J Martin,et al.  Effect of Exogenous and Endogenous Nitric Oxide on the Airway and Tissue Components of Lung Resistance in the Newborn Piglet , 1997, Pediatric Research.

[44]  R Bicknell,et al.  Nitric oxide synthase lies downstream from vascular endothelial growth factor-induced but not basic fibroblast growth factor-induced angiogenesis. , 1997, The Journal of clinical investigation.

[45]  W. Truog,et al.  Airway muscle in preterm infants: changes during development. , 1997, The Journal of pediatrics.

[46]  R. Pierce,et al.  Chronic lung injury in preterm lambs: disordered pulmonary elastin deposition. , 1997, The American journal of physiology.

[47]  Jesse D. Roberts,et al.  Inhaled Nitric Oxide and Persistent Pulmonary Hypertension of the Newborn , 1997 .

[48]  Cook,et al.  Inhaled nitric oxide in full-term and nearly full-term infants with hypoxic respiratory failure. , 1997, The New England journal of medicine.

[49]  A. Halbower,et al.  Effects of Inhaled Nitric Oxide on Pulmonary Edema and Lung Neutrophil Accumulation in Severe Experimental Hyaline Membrane Disease , 1997, Pediatric Research.

[50]  P. Dartevelle,et al.  Prevention of ischemia-reperfusion lung injury by inhaled nitric oxide in neonatal piglets. , 1996, Journal of applied physiology.

[51]  H. Granger,et al.  Nitric oxide mediates mitogenic effect of VEGF on coronary venular endothelium. , 1996, The American journal of physiology.

[52]  T. Billiar,et al.  The effect of nitric oxide on fetal pulmonary artery smooth muscle growth. , 1995, The Journal of surgical research.

[53]  Jesse D. Roberts,et al.  Continuous nitric oxide inhalation reduces pulmonary arterial structural changes, right ventricular hypertrophy, and growth retardation in the hypoxic newborn rat. , 1995, Circulation research.

[54]  S. Eddahibi,et al.  Continuous inhalation of nitric oxide protects against development of pulmonary hypertension in chronically hypoxic rats. , 1994, The Journal of clinical investigation.

[55]  J. Ando,et al.  Exogenous nitric oxide inhibits proliferation of cultured vascular endothelial cells. , 1994, Biochemical and biophysical research communications.

[56]  S. Soifer,et al.  Chronic nitric oxide inhibition in utero produces persistent pulmonary hypertension in newborn lambs. , 1994, The Journal of clinical investigation.

[57]  R. Klocke,et al.  THE AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE , 1994 .

[58]  D M Hyde,et al.  Lung morphometry: a new generation of tools and experiments for organ, tissue, cell, and molecular biology. , 1993, The American journal of physiology.

[59]  F. Morin,et al.  Treatment of persistent pulmonary hypertension in the newborn lamb by inhaled nitric oxide. , 1993, The Journal of pediatrics.

[60]  J. Wain,et al.  Inhaled nitric oxide reverses pulmonary vasoconstriction in the hypoxic and acidotic newborn lamb. , 1993, Circulation research.

[61]  J. Drazen,et al.  Bronchodilator action of inhaled nitric oxide in guinea pigs. , 1992, The Journal of clinical investigation.

[62]  E. Shaffer,et al.  Low-dose inhalational nitric oxide in persistent pulmonary hypertension of the newborn , 1992, The Lancet.

[63]  Jesse D. Roberts,et al.  Inhaled nitric oxide in persistent pulmonary hypertension of the newborn , 1992, The Lancet.

[64]  J. Wain,et al.  Inhaled Nitric Oxide: A Selective Pulmonary Vasodilator Reversing Hypoxic Pulmonary Vasoconstriction , 1991, Circulation.

[65]  J. Tomashefski,et al.  Morphometric analysis of the lung in bronchopulmonary dysplasia. , 1991, The American review of respiratory disease.

[66]  A. Cornelis,et al.  Different patterns of pulmonary sequelae after hyaline membrane disease: heterogeneity of bronchopulmonary dysplasia? A clinicopathologic study. , 1991, Biology of the neonate.

[67]  S. Abman,et al.  Role of endothelium-derived relaxing factor during transition of pulmonary circulation at birth. , 1990, The American journal of physiology.

[68]  A. Hislop,et al.  Pulmonary vascular damage and the development of cor pulmonale following hyaline membrane disease , 1990, Pediatric pulmonology.

[69]  A. Hassid,et al.  Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells. , 1989, The Journal of clinical investigation.

[70]  D. van Velzen,et al.  Ventilator‐Related Pathology in the Extremely Immature Lung , 1989, Pathology.

[71]  V. Bhutani,et al.  Evaluation of neonatal pulmonary mechanics and energetics: A two factor least mean square analysis , 1988, Pediatric pulmonology.

[72]  R. Guthrie,et al.  Early onset of airway reactivity in premature infants with bronchopulmonary dysplasia. , 1987, The American review of respiratory disease.

[73]  E. Bancalari,et al.  Serial determination of pulmonary function in infants with chronic lung disease. , 1987, The Journal of pediatrics.

[74]  T. J. Breen,et al.  Biostatistical Analysis (2nd ed.). , 1986 .

[75]  P. K. Smith,et al.  Measurement of protein using bicinchoninic acid. , 1985, Analytical biochemistry.

[76]  R. Wolfe,et al.  Pulmonary vascular response to oxygen in infants with severe bronchopulmonary dysplasia. , 1985, Pediatrics.

[77]  G. Vawter,et al.  Bronchopulmonary dysplasia: a morphometric study with emphasis on the pulmonary vasculature. , 1984, Pediatric pathology.

[78]  R. Burstein,et al.  Evaluation of infants with bronchopulmonary dysplasia using cardiac catheterization. , 1982, Pediatrics.

[79]  U. K. Laemmli,et al.  Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.

[80]  W. Northway,et al.  Pulmonary disease following respirator therapy of hyaline-membrane disease. Bronchopulmonary dysplasia. , 1967, The New England journal of medicine.

[81]  J. Beazell,et al.  Measurement of Pulmonary Edema , 1965, Circulation research.

[82]  J. Emery,et al.  The Number of Alveoli in the Terminal Respiratory Unit of Man During Late Intrauterine Life and Childhood , 1960, Archives of disease in childhood.